Arbutus Biopharma Corporation Soared
Fri, Dec 20, 2019 at 06:48 PM
Arbutus Biopharma Corporation (ABUS:NASDAQ) rocketted at $2.89, representing a gain of 26.8%. On Thu 19 Dec 19, ABUS:NASDAQ touched a New 2-Week Intraday Low of $2.2.
About Arbutus Biopharma Corporation (ABUS:NASDAQ)
Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.
Top 10 Gainers:
- DropCar, Inc. (DCAR:NASDAQ), 106.9%
- LAIX Inc. (LAIX:NYSE), 85.51%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 44.67%
- Cortexyme, Inc. (CRTX:NASDAQ), 39.5%
- China Online Education Group (COE:NYSE), 37.36%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 29.73%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 28.57%
- Arbutus Biopharma Corporation (ABUS:NASDAQ), 26.75%
- iBio, Inc. (IBIO:NYSEMKT), 25.58%